Pfizer Eyes M&A Opportunities with $6-Billion Firepower

Pfizer reportedly holds $6-billion in capital for potential mergers and acquisitions, according to Guggenheim. The company plans to target transactions ranging from hundreds of millions to low billions, with a strategic focus on bolstering its portfolio in internal medicine, immunology, and inflammation.